MicroRNA expression at diagnosis adds relevant prognostic information to molecular categorization in patients with intermediate-risk cytogenetic acute myeloid leukemia (original) (raw)

• Grossmann V, Schnittger S, Kohlmann A, Eder C, Roller A, Dicker F et al. A novel hierarchical prognostic model of AML solely based on molecular mutations. Blood 2012; 120: 2963–2972.
  Article CAS PubMed Google Scholar
• Döhner H, Estey EH, Amadori S, Appelbaum FR, Buchner T, Burnett AK et al. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet. Blood 2010; 115: 453–474.
  Article PubMed Google Scholar
• Grimwade D, Hills RK, Moorman AV, Walker H, Chatters S, Goldstone AH et al. Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials. Blood 2010; 116: 354–365.
  Article CAS PubMed Google Scholar
• Schlenk RF, Dohner K, Krauter J, Frohling S, Corbacioglu A, Bullinger L et al. Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1909–1918.
  Article CAS PubMed Google Scholar
• Chen J, Odenike O, Rowley JD . Leukaemogenesis: more than mutant genes. Nat Rev Cancer 2010; 10: 23–36.
  Article CAS PubMed PubMed Central Google Scholar
• Garzon R, Liu S, Fabbri M, Liu Z, Heaphy CE, Callegari E et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009; 113: 6411–6418.
  Article CAS PubMed PubMed Central Google Scholar
• Schotte D, Pieters R, Den Boer M . MicroRNAs in acute leukemia: from biological players to clinical contributors. Leukemia 2011; 26: 1–12.
  Article PubMed Google Scholar
• Dixon-McIver A, East P, Mein CA, Cazier JB, Molloy G, Chaplin T et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One 2008; 3: e2141.
  Article PubMed PubMed Central Google Scholar
• Jongen-Lavrencic M, Sun SM, Dijkstra MK, Valk PJ, Lowenberg B . MicroRNA expression profiling in relation to the genetic heterogeneity of acute myeloid leukemia. Blood 2008; 111: 5078–5085.
  Article CAS PubMed Google Scholar
• Diaz-Beya M, Navarro A, Ferrer G, Diaz T, Gel B, Camos M et al. Acute myeloid leukemia with translocation (8;16)(p11;p13) and MYST3-CREBBP rearrangement harbors a distinctive microRNA signature targeting RET proto-oncogene. Leukemia 2012; 27: 595–603.
  Article PubMed Google Scholar
• Marcucci G, Mrozek K, Radmacher MD, Garzon R, Bloomfield CD . The prognostic and functional role of microRNAs in acute myeloid leukemia. Blood 2011; 117: 1121–1129.
  Article CAS PubMed PubMed Central Google Scholar
• Garzon R, Garofalo M, Martelli MP, Briesewitz R, Wang L, Fernandez-Cymering C et al. Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci USA 2008; 105: 3945–3950.
  Article CAS PubMed PubMed Central Google Scholar
• Marcucci G, Radmacher MD, Maharry K, Mrozek K, Ruppert AS, Paschka P et al. MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008; 358: 1919–1928.
  Article CAS PubMed Google Scholar
• Marcucci G, Maharry K, Radmacher MD, Mrozek K, Vukosavljevic T, Paschka P et al. Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study. J Clin Oncol 2008; 26: 5078–5087.
  Article CAS PubMed PubMed Central Google Scholar
• Garzon R, Volinia S, Liu CG, Fernandez-Cymering C, Palumbo T, Pichiorri F et al. MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008; 111: 3183–3189.
  Article CAS PubMed PubMed Central Google Scholar
• Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT et al. Distinct microRNA expression profiles in acute myeloid leukemia with common translocations. Proc Natl Acad Sci USA 2008; 105: 15535–15540.
  Article CAS PubMed PubMed Central Google Scholar
• Li Z, Huang H, Chen P, He M, Li Y, Arnovitz S et al. miR-196b directly targets both HOXA9/MEIS1 oncogenes and FAS tumour suppressor in MLL-rearranged leukaemia. Nat Commun 2012; 3: 688.
  PubMed PubMed Central Google Scholar
• Sun SM, Rockova V, Bullinger L, Dijkstra MK, Dohner H, Lowenberg B et al. The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML. Leukemia 2012; 27: 100–106.
  Article PubMed Google Scholar
• Schwind S, Maharry K, Radmacher MD, Mrozek K, Holland KB, Margeson D et al. Prognostic significance of expression of a single microRNA, miR-181a, in cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study. J Clin Oncol 2010; 28: 5257–5264.
  Article CAS PubMed PubMed Central Google Scholar
• Eisfeld AK, Marcucci G, Maharry K, Schwind S, Radmacher MD, Nicolet D et al. miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia. Blood 2012; 120: 249–258.
  Article CAS PubMed PubMed Central Google Scholar
• Garzon R, Croce CM . MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008; 15: 352–358.
  Article CAS PubMed Google Scholar
• Vasilatou D, Papageorgiou S, Pappa V, Papageorgiou E, Dervenoulas J . The role of microRNAs in normal and malignant hematopoiesis. Eur J Haematol 2010; 84: 1–16.
  Article CAS PubMed Google Scholar
• Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D et al. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834–838.
  Article CAS PubMed Google Scholar
• Calin GA, Croce CM . MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857–866.
  Article CAS PubMed Google Scholar
• Agirre X, Martínez-Climent JÁ, Odero M, Prósper F . Epigenetic regulation of miRNA genes in acute leukemia. Leukemia 2011; 26: 395–403.
  Article PubMed Google Scholar
• Shaham L, Binder V, Gefen N, Borkhardt A, Izraeli S . MiR-125 in normal and malignant hematopoiesis. Leukemia 2012; 26: 2011–2018.
  Article CAS PubMed Google Scholar
• Thiede C, Steudel C, Mohr B, Schaich M, Schakel U, Platzbecker U et al. Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis. Blood 2002; 99: 4326–4335.
  Article CAS PubMed Google Scholar
• Boissel N, Renneville A, Biggio V, Philippe N, Thomas X, Cayuela JM et al. Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype. Blood 2005; 106: 3618–3620.
  Article CAS PubMed Google Scholar
• Fröhling S, Schlenk RF, Stolze I, Bihlmayr J, Benner A, Kreitmeier S et al. CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations. J Clin Oncol 2004; 22: 624–633.
  Article PubMed Google Scholar
• Navarro A, Marrades RM, Vinolas N, Quera A, Agusti C, Huerta A et al. MicroRNAs expressed during lung cancer development are expressed in human pseudoglandular lung embryogenesis. Oncology 2009; 76: 162–169.
  Article CAS PubMed Google Scholar
• Simon R, Lam A, Li MC, Ngan M, Menenzes S, Zhao Y . Analysis of gene expression data using BRB-ArrayTools. Cancer Inform 2007; 3: 11–17.
  Article PubMed PubMed Central Google Scholar
• Gray RJ . A class of K-sample tests for comparing the cumulative incidence of a competing risk. Ann Stat 1988; 16: 1141–1154.
  Article Google Scholar
• Fine JP, Gray RJ . A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94: 496–509.
  Article Google Scholar
• Kanda Y . Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2012; 48: 452–458.
  Article PubMed PubMed Central Google Scholar
• Patel JP, Gönen M, Figueroa ME, Fernandez H, Sun Z, Racevskis J et al. Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med 2012; 366: 1079–1089.
  Article CAS PubMed PubMed Central Google Scholar
• The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013; 368: 2059–2074.
  Article PubMed Central Google Scholar
• Bartel DP . MicroRNAs: target recognition and regulatory functions. Cell 2009; 136: 215–233.
  Article CAS PubMed PubMed Central Google Scholar
• Rücker F, Russ A, Cocciardi S, Kett H, Schlenk R, Botzenhardt U et al. Altered miRNA and gene expression in acute myeloid leukemia with complex karyotype identify networks of prognostic relevance. Leukemia 2012; 27: 353–361.
  Article PubMed Google Scholar
• Popovic R, Riesbeck LE, Velu CS, Chaubey A, Zhang J, Achille NJ et al. Regulation of mir-196b by MLL and its overexpression by MLL fusions contributes to immortalization. Blood 2009; 113: 3314–3322.
  Article CAS PubMed PubMed Central Google Scholar
• Danen-van Oorschot AA, Kuipers JE, Arentsen‐Peters S, Schotte D, de Haas V, Trka J et al. Differentially expressed miRNAs in cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Pediatr Blood Cancer 2012; 58: 715–721.
  Article PubMed Google Scholar
• Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Muller SC, Ellinger J . Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World J Urol 2012 doi:10.1007/s00345-012-1010-2.
  Article PubMed Google Scholar
• Navarro A, Diaz T, Martinez A, Gaya A, Pons A, Gel B et al. Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood 2009; 114: 2945–2951.
  Article CAS PubMed Google Scholar
• Wu S, Lin Y, Xu D, Chen J, Shu M, Zhou Y et al. MiR-135a functions as a selective killer of malignant glioma. Oncogene 2012; 31: 3866–3874.
  Article CAS PubMed Google Scholar
• Yamada Y, Hidaka H, Seki N, Yoshino H, Yamasaki T, Itesako T et al. Tumor-suppressive microRNA-135a inhibits cancer cell proliferation by targeting the c-MYC oncogene in renal cell carcinoma. Cancer Sci 2012; 104: 304–312.
  Article PubMed PubMed Central Google Scholar
• Nagel R, le Sage C, Diosdado B, van der Waal M, Oude Vrielink JA, Bolijn A et al. Regulation of the adenomatous polyposis coli gene by the miR-135 family in colorectal cancer. Cancer Res 2008; 68: 5795–5802.
  Article CAS PubMed Google Scholar
• Liu S, Guo W, Shi J, Li N, Yu X, Xue J et al. MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2012; 56: 389–396.
  Article CAS PubMed Google Scholar
• Chen Y, Zhang J, Wang H, Zhao J, Xu C, Du Y et al. miRNA-135a promotes breast cancer cell migration and invasion by targeting HOXA10. BMC Cancer 2012; 12: 111.
  Article CAS PubMed PubMed Central Google Scholar
• Zhou W, Li X, Liu F, Xiao Z, He M, Shen S et al. MiR-135a promotes growth and invasion of colorectal cancer via metastasis suppressor 1 in vitro. Acta Biochim Biophys Sin 2012; 44: 838–846.
  Article CAS PubMed Google Scholar
• Li C, Nie H, Wang M, Su L, Li J, Yu B et al. MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett 2012; 320: 189–197.
  Article CAS PubMed Google Scholar
• Weng C, Dong H, Chen G, Zhai Y, Bai R, Hu H et al. miR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin. Cancer Lett 2012; 323: 171–179.
  Article CAS PubMed Google Scholar
• Tsai KW, Wu CW, Hu LY, Li SC, Liao YL, Lai CH et al. Epigenetic regulation of miR-34b and miR-129 expression in gastric cancer. Int J Cancer 2011; 129: 2600–2610.
  Article CAS PubMed Google Scholar
• Stark MS, Tyagi S, Nancarrow DJ, Boyle GM, Cook AL, Whiteman DC et al. Characterization of the melanoma miRNAome by deep sequencing. PLoS One 2010; 5: e9685.
  Article PubMed PubMed Central Google Scholar
• Schotte D, Akbari Moqadam F, Lange-Turenhout EA, Chen C, van Ijcken WF, Pieters R et al. Discovery of new microRNAs by small RNAome deep sequencing in childhood acute lymphoblastic leukemia. Leukemia 2011; 25: 1389–1399.
  Article CAS PubMed Google Scholar